当前位置:首页>产品中心>单抗/多抗>Anti-Human EFTUD2 Polyclonal Antibody|抗人EFTUD2多克隆抗体(靶标:人延伸因子Tu GTP结合结构域含蛋白2)

Anti-Human EFTUD2 Polyclonal Antibody|抗人EFTUD2多克隆抗体(靶标:人延伸因子Tu GTP结合结构域含蛋白2)

  • 货号:RB9THD650014
  • 价格:面议
  • 点击:300
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human, Mouse
靶标116 kDa U5 small nuclear ribonucleoprotein component, EFTUD2, Elongation factor Tu GTP-binding domain-containing protein 2, KIAA0031, SNRP116, SNU114 homolog, U5 snRNP-specific protein, 116 kDa, U5-11
免疫原E. coli - derived recombinant Human EFTUD2 (Thr661-Met972).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号Q15029
背景信息

116 kDa U5 small nuclear ribonucleoprotein component (EFTUD2) is a ~109 kDa protein. Required for pre-mRNA splicing as component of the spliceosome, including pre-catalytic, catalytic and post-catalytic spliceosomal complexes. Component of the U5 snRNP and the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable).

1. Oka, Y. et al. (2014) EMBO reports 15, 956-64. PMID: 25092792
2. Bertram, K. et al. (2017) Nature 542, 318-323. PMID: 28076346
3. Zhang, X. et al. (2017) Cell 169, 918-929.e14. PMID: 28502770
4. Bertram, K. et al. (2017) Cell 170, 701-713.e11. PMID: 28781166
5. Zhan, X. et al. (2018) Science (New York, N.Y.) 359, 537-545. PMID: 29301961
6. Zhang, X. et al. (2018) Cell research 28, 307-322. PMID: 29360106
7. Haselbach, D. et al. (2018) Cell 172, 454-464.e11. PMID: 29361316
8. Zhan, X. et al. (2018) Cell research 28, 1129-1140. PMID: 30315277
9. Fica, SM. et al. (2019) Science (New York, N.Y.) 363, 710-714. PMID: 30705154
10. Liu, S. et al. (2006) RNA (New York, N.Y.) 12, 1418-30. PMID: 16723661
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 816
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 795
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 776
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 718
Anti-Durvalumab Non-Neutralizing Recombinant Antibody |程度伐利尤单抗非中和重组抗体(靶标:度伐利尤单抗非中和抗体) 1078
Anti-Durvalumab Non-Neutralizing Recombinant Antibody |抗度伐利尤单抗非中和重组抗体(靶标:度伐利尤单抗非中和抗体) 976
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 821
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 937
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 813
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 855
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody |抗阿替利珠单抗非中和重组抗体(靶标:阿替利珠单抗非中和抗体) 839
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody |抗阿替利珠单抗非中和重组抗体(靶标:阿替利珠单抗非中和抗体) 803
Anti-Atezolizumab Neutralizing Recombinant Antibody |抗阿替利珠单抗中和重组抗体(靶标:阿替利珠单抗中和抗体) 746
Anti-Atezolizumab Neutralizing Recombinant Antibody |抗阿替利珠单抗中和重组抗体(靶标:阿替利珠单抗中和抗体) 889
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 1026
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 758
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 752
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 753
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 748
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 704
总计 33037 个记录,共 1652 页,当前第 1647 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30